Literature DB >> 3297884

Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population.

W G Abbott, S Lillioja, A A Young, J K Zawadzki, H Yki-Järvinen, L Christin, B V Howard.   

Abstract

Relationships have been observed between lipoprotein concentrations and insulin action. These relationships may be important in explaining the association of insulin resistance and abnormalities of lipoprotein metabolism found in obesity, diabetes, and hypertriglyceridemia. We have measured plasma lipoprotein concentrations and indices of insulin action in 85 men and 56 women, all of whom were normolipidemic and had normal glucose tolerance. The subjects were obese Southwestern American Indians (body mass index 34 +/- 1). Insulin action was measured via the hyperinsulinemic clamp with simultaneous indirect calorimetry. Triglyceride concentrations were inversely related to rates of total insulin-mediated glucose disposal (in men and women, respectively, r = -.37, P less than .01; r = -.24, P less than .10), glucose storage (r = -.31, P less than .01; r = -.25, P less than .10), increase in glucose oxidation (r = -.29, P less than .01; r = -.24, P less than .10), and, in men only, suppression of endogenous glucose production (r = -.32, P less than .01). High-density lipoprotein (HDL) cholesterol concentration was positively related to rates of total insulin-mediated glucose disposal (r = .35, P less than .01; r = .33, P less than .05), increase in carbohydrate oxidation (r = .40, P less than .001; r = .39, P less than .001), suppression of endogenous glucose production (r = .24, P less than .05; r = .29, P less than .05), and, in men only, glucose storage (r = .35, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297884     DOI: 10.2337/diab.36.8.897

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  Insulin and atherosclerosis: villain, accomplice, or innocent bystander?

Authors:  P J Savage; M F Saad
Journal:  Br Heart J       Date:  1993-06

3.  Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.

Authors:  W G Abbott; B Swinburn; G Ruotolo; H Hara; L Patti; I Harper; S M Grundy; B V Howard
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

5.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects.

Authors:  Umesh Masharani; Ira D Goldfine; Jack F Youngren
Journal:  Metabolism       Date:  2009-07-15       Impact factor: 8.694

7.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Authors:  E Widén; A Ekstrand; C Saloranta; A Franssila-Kallunki; J Eriksson; C Schalin-Jäntti; L Groop
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

8.  A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.

Authors:  S M Haffner; L Mykkänen; D Robbins; R Valdez; H Miettinen; B V Howard; M P Stern; R Bowsher
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

9.  Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.

Authors:  H Vuorinen-Markkola; H Yki-Järvinen; M R Taskinen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

10.  Can the birth of a large infant predict risk for atherosclerotic vascular disease in the mother?

Authors:  J Spjuth; G Larsson; P Nilsson-Ehle; B Schersten; B Astedt
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.